# Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer

> **NCT00002553** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 50 (estimated)

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **DRUG:** cyclophosphamide
- **PROCEDURE:** allogeneic bone marrow transplantation
- **RADIATION:** low-LET cobalt-60 gamma ray therapy

## Key facts

- **NCT ID:** NCT00002553
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1990-08
- **Primary completion:** —
- **Final completion:** 2003-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2011-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002553, "Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*